|
|
Cell reprogramming for the creation of patient-specific pluripotent stem cells by defined factors |
Huiqun YIN1(), Hongguo CAO1, Yunhai ZHANG1, Yong TAO1, Xiaorong ZHANG1(), Heng WANG1 |
1. College of Animal Science and Technology, Anhui Agricultural University, Hefei 230036, China;; 2. Anhui Provincial Animals Genetic Resources Conservation Center, Hefei 231283, China |
|
|
Abstract Pluripotent stem cells (PSCs), characterized by being able to differentiate into various types of cells, are generally regarded as the most promising sources for cell replacement therapies. However, as typical PSCs, embryonic stem cells (ESCs) are still far away from human clinics so far due to ethical issues and immune rejection response. One way to avoid such problems is to use stem cells derived from autologous somatic cells. Up to date, PSCs could be obtained by reprogramming somatic cells to pluripotent state with approaches including somatic cell nuclear transfer (SCNT), fusion with stem cells, coculture with cells’ extracts, and induction with defined factors. Among these, through reprogramming somatic cells directly by retroviral transduction of transcription factors, induced pluripotent stem (iPS) cells have been successfully generated in both mouse and human recently. These iPS cells shared similar morphology and growth properties to ESCs, could express ESCs marker genes, and could produce adult or germline-competent chimaeras and differentiate into a variety of cell types, including germ cells. Moreover, with iPS technique, patient specific PSCs could be derived more easily from handful somatic cells in human without immune rejection responses innately connected to ESCs. Consequently, generation of iPS cells would be of great help to further understand disease mechanisms, drug screening, and cell transplantation therapies as well. In summary, the recent progress in the study of cell reprogramming for the creation of patient-specific pluripotent stem cells, some existing problems, and research perspectives were suggested.
|
Keywords
somatic cells
pluripotent stem cells
iPS cells
reprogramming
|
Corresponding Author(s):
YIN Huiqun,Email:milklecherry@163.com; ZHANG Xiaorong,Email:zxr@ahau.edu.cn
|
Issue Date: 05 June 2009
|
|
1 |
Adhikary S, Eilers M (2005). Transcriptional regulation and transformation by Myc proteins. Nat Rev Mol Cell Biol , 6: 635-645 doi: 10.1038/nrm1703
|
2 |
Alon U (2007). Network motifs: theory and experimental approaches. Nat Rev Genet , 8: 450-461 doi: 10.1038/nrg2102
|
3 |
Aoi T, Yae K, Nakagawa M, Ichisaka T, Okita K, Takahashi K, Chiba T, Yamanaka S (2008). Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science , 321(5889): 699-702 doi: 10.1126/science.1154884
|
4 |
Blelloch R, Venere M, Yen J, Ramalho-Santos M (2007). Generation of induced pluripotent stem cells in the absence of drug selection. Cell Stem Cell , 1: 245-247 doi: 10.1016/j.stem.2007.08.008
|
5 |
Boyer L A, Lee T I, Cole M F, Johnstone S E, Levine S S, Zucker J P, Guenther M G, Kumar R M, Murray H L, Jenner R G, Gifford D K, Melton D A, Jaenisch R, Young R A (2005). Core transcriptional regulatory circuitry in human embryonic stem cells. Cell , 122: 947-956 doi: 10.1016/j.cell.2005.08.020
|
6 |
Brambrink T, Foreman R, Welstead G G, Lengner C J, Wernig M, Suh H, Jaenisch R (2008). Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells. Cell Stem Cell , 2: 151-159 doi: 10.1016/j.stem.2008.01.004
|
7 |
Bru T, Clarke C, McGrew M J, Sang H M, Wilmut I, Blow J J (2008). Rapid induction of pluripotency genes after exposure of human somatic cells to mouse ES cell extracts. Exp Cell Res , 314(14): 2634-2642 doi: 10.1016/j.yexcr.2008.05.009
|
8 |
Cartwright P, McLean C, Sheppard A, Rivett D, Jones K, Dalton S (2005). LIF/STAT3 controls ES cell self-renewal and pluripotency by a Myc-dependent mechanism. Development , 132: 885-896 doi: 10.1242/dev.01670
|
9 |
Cawley S, Bekiranov S, Ng H H, Kapranov P, Sekinger E A, Kampa D, Piccolboni A, Sementchenko V, Cheng J, Williams A J, Wheeler R, Wong B, Drenkow J, Yamanaka M, Patel S, Brubaker S, Tammana H, Helt G, Struhl K, Gingeras T R (2004). Unbiased mapping of transcription factor binding sites along human chromosomes 21 and 22 points to widespread regulation of noncoding RNAs. Cell , 116: 499-509 doi: 10.1016/S0092-8674(04)00127-8
|
10 |
Collas P, Taranger C K (2006a). Toward reprogramming cells to pluripotency. Ernst Schering Res Found Workshop , 60: 47-67 doi: 10.1007/3-540-31437-7_5
|
11 |
Collas P, Taranger C K (2006b). Epigenetic reprogramming of nuclei using cell extracts. Stem Cell Rev , 2: 309-317 doi: 10.1007/BF02698058
|
12 |
Collas P, Taranger C K, Boquest A C, Noer A, Dahl J A (2006). On the way to reprogramming cells to pluripotency using cell-free extracts. Reproductive Bio Medicine , 12: 762-770
|
13 |
Cowan C A, Atienza J, Melton D A, Eggan K (2005). Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells. Science , 309: 1369-1373 doi: 10.1126/science.1116447
|
14 |
Darr H, Benvenisty N (2006). Factors involved in self-renewal and pluripotency of embryonic stem cells. Handb Exp Pharmacol , 174: 1-19
|
15 |
Dimos J T, Rodolfa K T, Niakan K K, Weisenthal L M, Mitsumoto H, Chung W, Croft G F, Saphier G, Leibel R, Goland R, Wichterle H, Henderson C E, Eggan K (2008). Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science , 321(5893): 1218-1221 doi: 10.1126/science.1158799
|
16 |
Dominguez-Sola D, Ying C Y, Grandori C, Ruggiero L, Chen B, Li M, Galloway D A, Gu W, Gautier J, Dalla-Favera R (2007). Nontranscriptional control of DNA replication by c-Myc. Nature , 448: 445-451 doi: 10.1038/nature05953
|
17 |
Fong H, Hohenstein K A, Donovan P J (2008). Regulation of Self-renewal and pluripotency by Sox2 in human embryonic stem cells. Stem Cells , 26(8): 1931-1938 doi: 10.1634/stemcells.2007-1002
|
18 |
Grinnemo K H, Sylvén C, Hovatta O, Dellgren G, Corbascio M (2008). Immunogenicity of human embryonic stem cells. Cell Tissue Res , 331: 67-78 doi: 10.1007/s00441-007-0486-3
|
19 |
Hanna J, Markoulaki S, Schorderet P, Carey B W, Beard C, Wernig M, Creyghton M P, Steine E J, Cassady J P, Foreman R, Lengner C J, Dausman J A, Jaenisc R (2008). Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency. Cell , 133: 250-264 doi: 10.1016/j.cell.2008.03.028
|
20 |
Hanna J, Wernig M, Markoulaki S, Sun C W, Meissner A, Cassady J P, Beard C, Brambrink T, Wu L C, Townes T M, Jaenisch R (2007). Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science , 318: 1920-1923
|
21 |
Hansis C, Barreto G, Maltry N, Niehrs C (2004). Nuclear reprogramming of human somatic cells by xenopus egg extract requires BRG1. Curr Biol , 14: 1475-1480 doi: 10.1016/j.cub.2004.08.031
|
22 |
Harley V R, Lovell-Badge R, Goodfellow P N (1994). Definition of a consensus DNA binding site for SRY. Nucleic Acids Res , 22: 1500-1501 doi: 10.1093/nar/22.8.1500
|
23 |
Hochedlinger K, Jaenisch R (2006). Nuclear reprogramming and pluripotency. Nature , 441: 1061-1067 doi: 10.1038/nature04955
|
24 |
Jaenisch R, Young R (2002). Myc suppression of the p21 (Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage. Nature , 419: 729-734 doi: 10.1038/nature01119
|
25 |
Jaenisch R, Young R (2008). Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell , 132: 567-582 doi: 10.1016/j.cell.2008.01.015
|
26 |
Jiang J, Chan Y S, Loh Y H, Cai J, Tong G Q, Lim C A, Robson P, Zhong S, Ng H H (2008). A core Klf circuitry regulates self-renewal of embryonic stem cells. Nat Cell Biol , 10: 353-360 doi: 10.1038/ncb1698
|
27 |
Kfoury C (2007). Therapeutic cloning: promises and issues. Mcgill J Med , 10: 112-120
|
28 |
Kim J B, Zaehres H, Wu G, Gentile L, Ko K, Sebastiano V, Araúzo-Bravo M J, Ruau D, Han D W, Zenke M, Sch?ler H R (2008). Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors. Nature , 454(7204): 646-650 doi: 10.1038/nature07061
|
29 |
Klimanskaya I, Rosenthal N, Lanza R (2008). Derive and conquer: sourcing and differentiating stem cells for therapeutic applications. Nat Rev Drug Discov , 7: 131-142 doi: 10.1038/nrd2403
|
30 |
Knoepfler P S, Zhang X Y, Cheng P F, Gafken P R, McMahon S B, Eisenman R N (2006). Myc influences global chromatin structure. EMBO J , 25: 2723-2734 doi: 10.1038/sj.emboj.7601152
|
31 |
Kohda T, Inoue K, Ogonuki N, Miki H, Naruse M, Kaneko-Ishino T, Ogura A, Ishino F (2005). Variation in gene expression and aberrantly regulated chromosome regions in cloned mice. Biol Reprod , 73: 1302-1311 doi: 10.1095/biolreprod.105.044958
|
32 |
Lagarkova M A, Volchkov P Y, Lyakisheva A V, Philonenko E S, Kiselev S L (2006). Diverse epigenetic profile of novel human embryonic stem cell lines. Cell Cycle , 5: 416-420
|
33 |
Li Y, McClintick J, Zhong L, Edenberg H J, Yoder M C, Chan R J (2005). Murine embryonic stem cell differentiation is promoted by SOCS-3 and inhibited by the zinc finger transcription factor Klf4. Blood , 105: 635-637 doi: 10.1182/blood-2004-07-2681
|
34 |
Liao J, Wu Z, Wang Y, Cheng L, Cui C, Gao Y, Chen T, Rao L, Chen, S, Jia N, Dai H, Xin S, Kang J, Pei G, Xiao L (2008). Enhanced efficiency of generating induced pluripotent stem (iPS) cells from human somatic cells by a combination of six transcription factors. Cell Res , 18: 600-603 doi: 10.1038/cr.2008.51
|
35 |
Lin T, Chao C, Saito S, Mazur S J, Murphy M E, Appella E, Xu Y (2005). p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression. Nat Cell Bio , 7: 165-171 doi: 10.1038/ncb1211
|
36 |
Lowry W E, Richter L, Yachechko R, Pyle A D, Tchieu J, Sridharan R, Clark A T, Plath K (2008). Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc Natl Acad Sci U S A , 105: 2883-2888 doi: 10.1073/pnas.0711983105
|
37 |
Maherali N, Sridharan R, Xie W, Utikal J, Eminli S, Arnold K, Stadtfeld M, Yachechko R, Tchieu J, Jaenisch R, Plath K, Hochedlinger K (2007). Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell , 1: 55-70 doi: 10.1016/j.stem.2007.05.014
|
38 |
Mali P, Ye Z, Hommond H H, Yu X, Lin J, Chen G, Zou J, Cheng L (2008). Improved efficiency and pace of generating induced pluripotent stem cells from human adult and fetal fibroblasts. Stem Cells , 26(8): 1998-2005 doi: 10.1634/stemcells.2008-0346
|
39 |
Matsumura H, Tada M, Otsuji T, Yasuchika K, Nakatsuji N, Surani A, Tada T (2007). Targeted chromosome elimination from ES-somatic hybrid cells. Nat Methods , 4: 23-25 doi: 10.1038/nmeth973
|
40 |
Meissner A, Wernig M, Jaenisch R (2007). Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nat Biotechnol , 25: 1177-1181 doi: 10.1038/nbt1335
|
41 |
Miller R A, Ruddle F H (1976). Pluripotent teratocarcinoma-thymus somatic cell hybrids, Cell , 9: 45-55 doi: 10.1016/0092-8674(76)90051-9
|
42 |
Nakagawa M, Koyanagi M, Tanabe K, Takahashi K, Ichisaka T, Aoi T, Okita K, Mochiduki Y, Takizawa N, Yamanaka S (2008). Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechno , 26: 101-106 doi: 10.1038/nbt1374
|
43 |
Nakatake Y, Fukui N, Iwamats Y, Masui S, Takahashi K, Yagi R, Yagi K, Miyazaki J, Matoba R, Ko M S, Niwa H (2006). Klf4 cooperates with Oct3/4 and Sox2 to activate the Lefty1 core promoter in embryonic stem cells. Mol Cell Biol , 26(20): 7772-7782 doi: 10.1128/MCB.00468-06
|
44 |
Neri T, Monti M, Rebuzzini P, Merico V, Garagna S, Redi C A, Zuccotti M (2007). Mouse fibroblasts are reprogrammed to Oct-4 and Rex-1 gene expression and alkaline phosphatase activity by embryonic stem cell extracts. Cloning Stem Cells , 9: 394-406 doi: 10.1089/clo.2006.0011
|
45 |
Okamoto K, Okazawa H, Okuda A, Sakai M, Muramatsu M, Hamada H (1990). A novel octamer binding transcription factor is differentially expressed in mouse embryonic cells. Cell , 60: 461-472 doi: 10.1016/0092-8674(90)90597-8
|
46 |
Okita K, Ichisaka T, Yamanaka S (2007). Generation of germline-competent induced pluripotent stem cells. Nature , 448: 313-317 doi: 10.1038/nature05934
|
47 |
Park I H, Daley G Q (2007). Debugging cellular reprogramming. Nat Cell Biol , 9: 871-873 doi: 10.1038/ncb0807-871
|
48 |
Park I H, Zhao R, West J A, Yabuuchi A, Huo H, Ince T A, Lerou P H, Lensch M W, Daley G Q (2008). Reprogramming of human somatic cells to pluripotency with defined factors. Nature , 451: 141-146 doi: 10.1038/nature06534
|
49 |
Pasquinelli A E, Hunter S, Bracht J (2005). MicroRNAs: a developing story. Curr Opin Genet Dev , 15: 200-205 doi: 10.1016/j.gde.2005.01.002
|
50 |
Pesce M, Gross M K, Scholer H R (1998). In line with our ancestors: Oct-4 and the mammalian germ. Bioessays , 20: 722-732 doi: 10.1002/(SICI)1521-1878(199809)20:9<722::AID-BIES5>3.0.CO;2-I
|
51 |
Pochampally R R, Neville B T, Schwarz E J, Li M M, Prockop D J (2004). Rat adult stem cells (marrow stromal cells) engraft and differentiate in chick embryos without evidence of cell fusion. Proc Natl Acad Sci U S A , 101: 9282-9285 doi: 10.1073/pnas.0401558101
|
52 |
Qin D, Li W, Zhang J, Pei D (2007). Direct generation of ES-like cells from unmodified mouse embryonic fibroblasts by Oct4/Sox2/Myc/Klf4. Cell Res , 17: 959-962 doi: 10.1038/cr.2007.92
|
53 |
Rosner M H, Vigano M A, Ozato K, Timmons P M, Poirier F, Rigby P W, Staudt L M (1990). A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo. Nature , 345: 686-692 doi: 10.1038/345686a0
|
54 |
Rowland B D, Bernards R, Peeper D S (2005). The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene. Nat Cell Biol , 7: 1074-1082 doi: 10.1038/ncb1314
|
55 |
Silva J, Chambers I, Pollard S, Smith A (2006). Nanog promotes transfer of pluripotency after cell fusion. Nature , 441: 997-1001 doi: 10.1038/nature04914
|
56 |
Smith S L, Everts R E, Tian X C, Du F, Sung L Y, Rodriguez-Zas S L, Jeong B S, Renard J P, Lewin H A, Yang X (2005). Global gene expression profiles reveal significant nuclear reprogramming by the blastocyst stage after cloning. Proc Natl Acad Sci U S A , 102: 17582-17587 doi: 10.1073/pnas.0508952102
|
57 |
Sonia S, Michel P (2007). Oct-3/4: Not just a gatekeeper of pluripotency for embryonic stem cell, a cell fate instructor through a gene dosage effect. Cell Cycle , 6: 8-10
|
58 |
Stadtfeld M, Brennand K, Hochedlinger K (2008b). Reprogramming of pancreatic Beta cells into induced pluripotent stem cells. Curr Biol , 18: 890-894 doi: 10.1016/j.cub.2008.05.010
|
59 |
Stadtfeld M, Maherali N, Breault D T, Hochedlinger K (2008a). Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse. Cell Stem Cell , 2: 230-240 doi: 10.1016/j.stem.2008.02.001
|
60 |
Tada M, Morizane A, Kimura H, Kawasaki H, Ainscough J F, Sasai Y, Nakatsuji N, Tada T (2003). Pluripotency of reprogrammed somatic genomes in embryonic stem hybrid cells. Dev Dyn , 227: 504-510 doi: 10.1002/dvdy.10337
|
61 |
Tada M, Tada T, Lefebvre L, Barton S C, Surani, M A (1997). Embryonic germ cells induce epigenetic reprogramming of somatic nucleus in hybrid cells. EMBO J , 16: 6510-6520 doi: 10.1093/emboj/16.21.6510
|
62 |
Takahashi K, Okita K, Nakagawa M, Yamanaka S (2007a). Induction of pluripotent stem cells from fibroblast cultures. Nat Protoc , 2: 3081-3089 doi: 10.1038/nprot.2007.418
|
63 |
Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S (2007b). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell , 131: 861-872 doi: 10.1016/j.cell.2007.11.019
|
64 |
Takahashi K, Yamanaka S (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell , 126: 663-676 doi: 10.1016/j.cell.2006.07.024
|
65 |
Tateishi K, He J, Taranova O, Liang G, Liang G, D'Alessio A C, Zhang Y (2008). Generation of insulin-secreting islet-like clusters from human skin fibroblasts. J Biol Chem , 283(46): 31601-31607
|
66 |
Tokuzawa Y, Kaiho E, Maruyama M, Takahashi K, Mitsui K, Maeda M, Niwa H, Yamanaka S (2003). Fbx15 is a novel target of Oct3/4 but is dispensable for embryonic stem cell self-renewal and mouse development. Mol Cell Biol , 23: 2699-2708 doi: 10.1128/MCB.23.8.2699-2708.2003
|
67 |
Wernig M, Meissner A, Cassady J P, Jaenisch R (2008). c-Myc is dispensable for direct reprogramming of mouse fibroblasts. Cell Stem Cell , 2: 10-12 doi: 10.1016/j.stem.2007.12.001
|
68 |
Wernig M, Meissner A, Foreman R, Brambrink T, Ku M, Hochedlinger K, Bernstein B E, Jaenisch R (2007). In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature , 448: 318-324 doi: 10.1038/nature05944
|
69 |
Wernig M, Zhao J P, Pruszak J, Hedlund E, Fu D, Soldner F, Broccoli V, Constantine-Paton M, Isacson O, Jaenisch R (2008). Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc Natl Acad Sci U S A , 105: 5856-5861 doi: 10.1073/pnas.0801677105
|
70 |
Wood H B, Episkopou V (1999). Comparative expression of the mouse Sox1, Sox2 and Sox3 genes from pre-gastrulation to early somite stages. Mech Dev , 86: 197-201 doi: 10.1016/S0925-4773(99)00116-1
|
71 |
Yu J, Vodyanik M A, Smuga-Otto K, Antosiewicz-Bourget J, Frane J L, Tian S, Nie J, Jonsdottir G A, Ruotti V, Stewart R, Slukvin I I, Thomson J A (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science , 318: 1917-1920 doi: 10.1126/science.1151526
|
72 |
Zeineddine D, Papadimou E, Chebli K, Gineste M, Liu J, Grey C, Thurig S, Behfar A, Wallace V A, Skerjanc I S, Pucéat M (2006). Oct-3/4 dose dependently regulates specification of embryonic stem cells toward a cardiac lineage and early heart development. Dev Cell , 11: 535-546 doi: 10.1016/j.devcel.2006.07.013
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|